post injection Search Results


cell lysis buffer 2  (Bio-Techne corporation)
95
Bio-Techne corporation cell lysis buffer 2
Cell Lysis Buffer 2, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/post+injection/bio-techne+corporation___895347?v=Bio-Techne+corporation
Average 95 stars, based on 1 article reviews
cell lysis buffer 2 - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier
t1-weighted images prior to and post-gd-dtpa injection  (Berlex Laboratories Inc)
90
Berlex Laboratories Inc t1-weighted images prior to and post-gd-dtpa injection
T1 Weighted Images Prior To And Post Gd Dtpa Injection, supplied by Berlex Laboratories Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/post+injection/pm12594759-100-17-11?v=Berlex+Laboratories+Inc
Average 90 stars, based on 1 article reviews
t1-weighted images prior to and post-gd-dtpa injection - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
injectable 3d hydrogel scaffold with tailorable porosity post-implantation  (Verlag GmbH)
90
Verlag GmbH injectable 3d hydrogel scaffold with tailorable porosity post-implantation
Injectable 3d Hydrogel Scaffold With Tailorable Porosity Post Implantation, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/post+injection/pm24151286-7-23-11?v=Verlag+GmbH
Average 90 stars, based on 1 article reviews
injectable 3d hydrogel scaffold with tailorable porosity post-implantation - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
t1-weighted sequence post-contrast injection  (Technik GmbH)
90
Technik GmbH t1-weighted sequence post-contrast injection
T1 Weighted Sequence Post Contrast Injection, supplied by Technik GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/post+injection/pm18937154-150-34-33?v=Technik+GmbH
Average 90 stars, based on 1 article reviews
t1-weighted sequence post-contrast injection - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
post injection p i  (Siemens Healthineers)
86
Siemens Healthineers post injection p i
Whole-body imaging of tumor-bearing mice with difference sizes of tumors after SC injection of Cy5-peptides. (A) Experimental design of fluorescence imaging with Cy5-FUD, Cy5-PEG-FUD, and Cy5-PEG-mFUD. (B) Representative images of fluorescence imaging of 4T1 tumor-bearing mice subcutaneously injected with Cy5-FUD, Cy5-PEG-FUD, and Cy5-PEG-mFUD at 1, 2, and 3 weeks after the tumor (green arrows) implantation. The images were acquired at 24 h <t>post-injection.</t> (C) Quantification of fluorescence intensity in tumors of the images from Fig. 4B . Net radiant efficiency was obtained by subtracting the background fluorescence intensity before injection each week (means ± SD, n = 4–5). (D) Ex vivo images of the organs harvested after the 3-week whole animal imaging time points. (E) Quantification of fluorescence intensity of the images from Fig. 4D (means ± SD, n = 4–5 per group). *: P < 0.05, **: P < 0.01, ***: P < 0.001. Fig. 4A created with BioRender.com .
Post Injection P I, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/post+injection/pmc09841600-154-12-19?v=Siemens+Healthineers
Average 86 stars, based on 1 article reviews
post injection p i - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
post injection  (Guangzhou Biolight Biotechnology Co Ltd)
86
Guangzhou Biolight Biotechnology Co Ltd post injection
Whole-body imaging of tumor-bearing mice with difference sizes of tumors after SC injection of Cy5-peptides. (A) Experimental design of fluorescence imaging with Cy5-FUD, Cy5-PEG-FUD, and Cy5-PEG-mFUD. (B) Representative images of fluorescence imaging of 4T1 tumor-bearing mice subcutaneously injected with Cy5-FUD, Cy5-PEG-FUD, and Cy5-PEG-mFUD at 1, 2, and 3 weeks after the tumor (green arrows) implantation. The images were acquired at 24 h <t>post-injection.</t> (C) Quantification of fluorescence intensity in tumors of the images from Fig. 4B . Net radiant efficiency was obtained by subtracting the background fluorescence intensity before injection each week (means ± SD, n = 4–5). (D) Ex vivo images of the organs harvested after the 3-week whole animal imaging time points. (E) Quantification of fluorescence intensity of the images from Fig. 4D (means ± SD, n = 4–5 per group). *: P < 0.05, **: P < 0.01, ***: P < 0.001. Fig. 4A created with BioRender.com .
Post Injection, supplied by Guangzhou Biolight Biotechnology Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/post+injection/pmc12870914-186-13-21?v=Guangzhou+Biolight+Biotechnology+Co+Ltd
Average 86 stars, based on 1 article reviews
post injection - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
post glucose injection  (Eli Lilly)
86
Eli Lilly post glucose injection
Whole-body imaging of tumor-bearing mice with difference sizes of tumors after SC injection of Cy5-peptides. (A) Experimental design of fluorescence imaging with Cy5-FUD, Cy5-PEG-FUD, and Cy5-PEG-mFUD. (B) Representative images of fluorescence imaging of 4T1 tumor-bearing mice subcutaneously injected with Cy5-FUD, Cy5-PEG-FUD, and Cy5-PEG-mFUD at 1, 2, and 3 weeks after the tumor (green arrows) implantation. The images were acquired at 24 h <t>post-injection.</t> (C) Quantification of fluorescence intensity in tumors of the images from Fig. 4B . Net radiant efficiency was obtained by subtracting the background fluorescence intensity before injection each week (means ± SD, n = 4–5). (D) Ex vivo images of the organs harvested after the 3-week whole animal imaging time points. (E) Quantification of fluorescence intensity of the images from Fig. 4D (means ± SD, n = 4–5 per group). *: P < 0.05, **: P < 0.01, ***: P < 0.001. Fig. 4A created with BioRender.com .
Post Glucose Injection, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/post+injection/pmc12986748-105-16-4?v=Eli+Lilly
Average 86 stars, based on 1 article reviews
post glucose injection - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
post injection  (Kodak)
86
Kodak post injection
Whole-body imaging of tumor-bearing mice with difference sizes of tumors after SC injection of Cy5-peptides. (A) Experimental design of fluorescence imaging with Cy5-FUD, Cy5-PEG-FUD, and Cy5-PEG-mFUD. (B) Representative images of fluorescence imaging of 4T1 tumor-bearing mice subcutaneously injected with Cy5-FUD, Cy5-PEG-FUD, and Cy5-PEG-mFUD at 1, 2, and 3 weeks after the tumor (green arrows) implantation. The images were acquired at 24 h <t>post-injection.</t> (C) Quantification of fluorescence intensity in tumors of the images from Fig. 4B . Net radiant efficiency was obtained by subtracting the background fluorescence intensity before injection each week (means ± SD, n = 4–5). (D) Ex vivo images of the organs harvested after the 3-week whole animal imaging time points. (E) Quantification of fluorescence intensity of the images from Fig. 4D (means ± SD, n = 4–5 per group). *: P < 0.05, **: P < 0.01, ***: P < 0.001. Fig. 4A created with BioRender.com .
Post Injection, supplied by Kodak, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/post+injection/pm21062090__bc100308p_si_001-27-4-17?v=Kodak
Average 86 stars, based on 1 article reviews
post injection - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
post injection  (Princeton Instruments)
86
Princeton Instruments post injection
Whole-body imaging of tumor-bearing mice with difference sizes of tumors after SC injection of Cy5-peptides. (A) Experimental design of fluorescence imaging with Cy5-FUD, Cy5-PEG-FUD, and Cy5-PEG-mFUD. (B) Representative images of fluorescence imaging of 4T1 tumor-bearing mice subcutaneously injected with Cy5-FUD, Cy5-PEG-FUD, and Cy5-PEG-mFUD at 1, 2, and 3 weeks after the tumor (green arrows) implantation. The images were acquired at 24 h <t>post-injection.</t> (C) Quantification of fluorescence intensity in tumors of the images from Fig. 4B . Net radiant efficiency was obtained by subtracting the background fluorescence intensity before injection each week (means ± SD, n = 4–5). (D) Ex vivo images of the organs harvested after the 3-week whole animal imaging time points. (E) Quantification of fluorescence intensity of the images from Fig. 4D (means ± SD, n = 4–5 per group). *: P < 0.05, **: P < 0.01, ***: P < 0.001. Fig. 4A created with BioRender.com .
Post Injection, supplied by Princeton Instruments, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/post+injection/pmc12625341-186-12-21?v=Princeton+Instruments
Average 86 stars, based on 1 article reviews
post injection - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
injection products post operative acute pain local anesthetic  (Scilex Pharmaceuticals)
86
Scilex Pharmaceuticals injection products post operative acute pain local anesthetic
Whole-body imaging of tumor-bearing mice with difference sizes of tumors after SC injection of Cy5-peptides. (A) Experimental design of fluorescence imaging with Cy5-FUD, Cy5-PEG-FUD, and Cy5-PEG-mFUD. (B) Representative images of fluorescence imaging of 4T1 tumor-bearing mice subcutaneously injected with Cy5-FUD, Cy5-PEG-FUD, and Cy5-PEG-mFUD at 1, 2, and 3 weeks after the tumor (green arrows) implantation. The images were acquired at 24 h <t>post-injection.</t> (C) Quantification of fluorescence intensity in tumors of the images from Fig. 4B . Net radiant efficiency was obtained by subtracting the background fluorescence intensity before injection each week (means ± SD, n = 4–5). (D) Ex vivo images of the organs harvested after the 3-week whole animal imaging time points. (E) Quantification of fluorescence intensity of the images from Fig. 4D (means ± SD, n = 4–5 per group). *: P < 0.05, **: P < 0.01, ***: P < 0.001. Fig. 4A created with BioRender.com .
Injection Products Post Operative Acute Pain Local Anesthetic, supplied by Scilex Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/post+injection/sec_filing____850261_slash_000110465921148947_slash_tm2135241d1_ex99___1-159-21-51?v=Scilex+Pharmaceuticals
Average 86 stars, based on 1 article reviews
injection products post operative acute pain local anesthetic - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

Image Search Results


Whole-body imaging of tumor-bearing mice with difference sizes of tumors after SC injection of Cy5-peptides. (A) Experimental design of fluorescence imaging with Cy5-FUD, Cy5-PEG-FUD, and Cy5-PEG-mFUD. (B) Representative images of fluorescence imaging of 4T1 tumor-bearing mice subcutaneously injected with Cy5-FUD, Cy5-PEG-FUD, and Cy5-PEG-mFUD at 1, 2, and 3 weeks after the tumor (green arrows) implantation. The images were acquired at 24 h post-injection. (C) Quantification of fluorescence intensity in tumors of the images from Fig. 4B . Net radiant efficiency was obtained by subtracting the background fluorescence intensity before injection each week (means ± SD, n = 4–5). (D) Ex vivo images of the organs harvested after the 3-week whole animal imaging time points. (E) Quantification of fluorescence intensity of the images from Fig. 4D (means ± SD, n = 4–5 per group). *: P < 0.05, **: P < 0.01, ***: P < 0.001. Fig. 4A created with BioRender.com .

Journal: Journal of controlled release : official journal of the Controlled Release Society

Article Title: Multimodal Imaging Demonstrates Enhanced Tumor Exposure of PEGylated FUD Peptide in Breast Cancer

doi: 10.1016/j.jconrel.2022.08.028

Figure Lengend Snippet: Whole-body imaging of tumor-bearing mice with difference sizes of tumors after SC injection of Cy5-peptides. (A) Experimental design of fluorescence imaging with Cy5-FUD, Cy5-PEG-FUD, and Cy5-PEG-mFUD. (B) Representative images of fluorescence imaging of 4T1 tumor-bearing mice subcutaneously injected with Cy5-FUD, Cy5-PEG-FUD, and Cy5-PEG-mFUD at 1, 2, and 3 weeks after the tumor (green arrows) implantation. The images were acquired at 24 h post-injection. (C) Quantification of fluorescence intensity in tumors of the images from Fig. 4B . Net radiant efficiency was obtained by subtracting the background fluorescence intensity before injection each week (means ± SD, n = 4–5). (D) Ex vivo images of the organs harvested after the 3-week whole animal imaging time points. (E) Quantification of fluorescence intensity of the images from Fig. 4D (means ± SD, n = 4–5 per group). *: P < 0.05, **: P < 0.01, ***: P < 0.001. Fig. 4A created with BioRender.com .

Article Snippet: Longitudinal static PET/CT images were acquired at 2, 24, and 48 h post-injection (p.i.) using the μPET/CT Inveon scanner (Siemens Medical Solutions USA, Inc.).

Techniques: Imaging, Injection, Fluorescence, Ex Vivo

(A) Longitudinal imaging of tumor-bearing mice after SC injection of Cy5- peptides two weeks after tumor implantation (green arrows). The mice were imaged before the peptide injection, 24, 48, and 72 h post-injection. (B) Quantification of fluorescence intensity in the tumors of the images from Fig. 5A . The net radiant efficiency of each time point was obtained by subtracting the background fluorescence intensity of pre-injection images (means ± SD, n = 4–5). (C) Fluorescence imaging of the blood samples collected after injection of Cy5-peptides. The samples were collected 1, 3, 24, 48, and 72 h post-injection. (D) Quantification of fluorescence intensity of the images from Fig. 5C . The net radiant efficiency of each time point was obtained by subtracting the autofluorescence of the background blood samples (means ± SD, n = 4). *: P < 0.05, ***: P < 0.001.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Article Title: Multimodal Imaging Demonstrates Enhanced Tumor Exposure of PEGylated FUD Peptide in Breast Cancer

doi: 10.1016/j.jconrel.2022.08.028

Figure Lengend Snippet: (A) Longitudinal imaging of tumor-bearing mice after SC injection of Cy5- peptides two weeks after tumor implantation (green arrows). The mice were imaged before the peptide injection, 24, 48, and 72 h post-injection. (B) Quantification of fluorescence intensity in the tumors of the images from Fig. 5A . The net radiant efficiency of each time point was obtained by subtracting the background fluorescence intensity of pre-injection images (means ± SD, n = 4–5). (C) Fluorescence imaging of the blood samples collected after injection of Cy5-peptides. The samples were collected 1, 3, 24, 48, and 72 h post-injection. (D) Quantification of fluorescence intensity of the images from Fig. 5C . The net radiant efficiency of each time point was obtained by subtracting the autofluorescence of the background blood samples (means ± SD, n = 4). *: P < 0.05, ***: P < 0.001.

Article Snippet: Longitudinal static PET/CT images were acquired at 2, 24, and 48 h post-injection (p.i.) using the μPET/CT Inveon scanner (Siemens Medical Solutions USA, Inc.).

Techniques: Imaging, Injection, Tumor Implantation, Fluorescence

Intravital imaging of Cy5-FUD and Cy5-PEG-FUD in 4T1 mouse mammary carcinoma. After two weeks of tumor growth, images were acquired pre and post- 24 h SC injection of Cy5- peptides. SHG (collagen fibers) shown in grey, Cy5 (peptide) shown in cyan and vasculature in red. (A) Representative image of Cy5-FUD and Cy5-PEG-FUD in the TME pre-injection and 24 h post-injection, respectively. Scale bar = 150 μm. (B) Quantification of mean intensity of Cy5-labeled peptides. (C) Zoomed inset of Cy5-PEG-FUD 24 h p.i. Yellow arrows indicate Cy5-peptides localizing to cellular structures. Scale bar = 50 μm, ns: non-significant, ***: P < 0.001.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Article Title: Multimodal Imaging Demonstrates Enhanced Tumor Exposure of PEGylated FUD Peptide in Breast Cancer

doi: 10.1016/j.jconrel.2022.08.028

Figure Lengend Snippet: Intravital imaging of Cy5-FUD and Cy5-PEG-FUD in 4T1 mouse mammary carcinoma. After two weeks of tumor growth, images were acquired pre and post- 24 h SC injection of Cy5- peptides. SHG (collagen fibers) shown in grey, Cy5 (peptide) shown in cyan and vasculature in red. (A) Representative image of Cy5-FUD and Cy5-PEG-FUD in the TME pre-injection and 24 h post-injection, respectively. Scale bar = 150 μm. (B) Quantification of mean intensity of Cy5-labeled peptides. (C) Zoomed inset of Cy5-PEG-FUD 24 h p.i. Yellow arrows indicate Cy5-peptides localizing to cellular structures. Scale bar = 50 μm, ns: non-significant, ***: P < 0.001.

Article Snippet: Longitudinal static PET/CT images were acquired at 2, 24, and 48 h post-injection (p.i.) using the μPET/CT Inveon scanner (Siemens Medical Solutions USA, Inc.).

Techniques: Imaging, Injection, Labeling